Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity

Neuropeptides

Volumn 39, Issue 5, 2005, Pages 515-523

  Obuchowicz, E ^a   Krysiak, R ^a   Wieronska, J M ^b   Smialowska, M ^b   Herman, Z S ^a  

^a UNIVERSITY OF SILESIA   (Poland)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Haloperidol induced supersensitivity; Locomotion; Neuropeptide Y like immunoreactivity; NPY mRNA; Nucleus accumbens; Quinpirole; Rat; Stereotype; Striatum

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; HALOPERIDOL; MESSENGER RNA; NEUROPEPTIDE Y; QUINPIROLE; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; GROOMING; HYPERACTIVITY; IMMUNOREACTIVITY; INJECTION; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PREVALENCE; PRIORITY JOURNAL; PUTAMEN; QUANTITATIVE ANALYSIS; RAT; REARING; RNA ANALYSIS; SNIFFING; STEREOTYPY; SUPERSENSITIVITY;

ANIMALS; BEHAVIOR, ANIMAL; CORPUS STRIATUM; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; HALOPERIDOL; IN SITU HYBRIDIZATION; MALE; MOTOR ACTIVITY; NEUROPEPTIDE Y; QUINPIROLE; RATS; RATS, WISTAR; RNA, MESSENGER;

ANIMALIA;

EID: 26844437303     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2005.04.004     Document Type: Article

References (55)

1. 2+ channels Eur. J. Pharmacol. 294 1995 459 467
2. J. Arnt, K.P. Bogeso, J. Hyttel, and E. Meier Relative dopamine D1 and D2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats Pharmacol. Toxicol. 62 1988 121 130
3. J. Arnt, J. Hyttel, and J. Perregaard Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats Eur. J. Pharmacol. 133 1987 137 145
4. 3H]dopamine release from rat striatum by neuropeptide Y and σ receptor ligands Brain Res. 760 1997 210 217
5. V. Bernard, O. Laribi, A.I. Levey, and B. Bloch Subcellular redistribution of m2 muscarinic acetylcholine receptors in striatal interneurons in vivo after acute cholinergic stimulation J. Neurosci. 18 1998 10207 10218
6. C. Cannizarro, BC. Tel, S. Rose, BY. Zeng, and P. Jenner Increased neuropeptide Y mRNA expressoin in striatum in Parkinson's disease Mol. Brain Res. 110 2003 169 176
7. P.M. Carvey, A. Hitri, C.G. Goetz, C.M. Tanner, and H.L. Klawans Concurrent treatment with benztropine and haloperidol attenuates development of behavioural hypersensitivity but not dopamine receptor proliferation Life Sci. 42 1988 2207 2215
8. J.M. Delfs, and A.E. Kelley The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum Neuroscience 39 1990 59 67
9. M.E. De Quidt, and P.C. Emson Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system. I. Radioimmunoassay and chromatographic characterisation Neuroscience 18 1986 527 543
10. M.F. Egan, Y. Hurd, T.M. Hyde, D.R. Weinberger, R.J. Wyatt, and J.E. Kleinman Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptics-induced dyskinesias Synapse 18 1994 178 189
11. 2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin Brain Res. 581 1992 261 268
12. 2 receptor-induced [35S]GTPγS binding after haloperidol treatment Eur. J. Pharmacol. 382 1999 119 127
13. S.H.M. Gruber, and A.A. Mathé Effects of typical and atypical antipsychotics on neuropeptide Y in rat brain tissue and microdialysates from ventral striatum J. Neurosci. Res. 61 2000 458 463
14. 13-36 on the brain monoaminergic systems of the rat J. Neural. Transm. [GenSect] 79 1990 193 208
15. A.S. Horn, A.C. Cuello, and R.J. Miller Dopamine in the mesolimbic system of the rat brain: endogenous levels and the effects of drugs on the uptake mechanism and stimulation of adenylate cyclase activity J. Neurochem. 22 1974 265 270
16. A. Kask, and J. Harro Inhibition of amphetamine- and apomorphine-induced behavioural effects by neuropeptide Y Y1 receptor antagonist BIBO 3304 Neuropharmacology 39 2000 1292 1302
17. Y. Kawaguchi, C.J. Wilson, S.J. Augood, and P.C. Emson Striatal interneurones: chemical, physiological and morphological characterization Trends Neurosci. 18 1995 527 535
18. L. Kerkerian, P. Salin, and A. Nieoullon Pharmacological characterization of dopaminergic influence on expression of neuropeptide Y immunoreactivity by striatal neurons Neuroscience 26 1988 809 817
19. L. Kerkerian-Le Goff, C. Forni, D. Samuel, A. Bloc, N. Dusticier, and A. Nieoullon Intracerebroventricular administration of neuropeptide Y affects parameters of dopamine, glutamate and GABA activities in the rat striatum Brain Res. Bull. 28 1992 187 193
20. M.B. Knable, T.M. Hyde, M.F. Egan, M. Tosayali, R.J. Wyatt, and J.E. Kleinman Quantitative autoradiography of striatal dopamine D1, D2 and re-uptake sites in rats with vacuous chewing movements Brain Res. 646 1994 217 222
21. G.J. LaHoste, and J.F. Marshall Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density Synapse 12 1992 14 26
22. N. Lindefors, S. Brené, M. Herrera-Marschitz, and H. Persson Regulation of neuropeptide Y gene expression in rat brain Ann. N.Y. Acad. Sci. USA 611 1990 175 185
23. R. Longoni, L. Spina, and G. Di Chiara Permissive role of D-1 receptor stimulation for the expression of D-2 mediated behavioral responses: a quantitative phenomenological study in rats Life Sci. 41 1987 2135 2145
24. 2 receptor attenuates haloperidol-induced behavioural supersensitivity and receptor up ulation Eur. J. Pharmacol. 231 1993 191 196
25. C. Marin, T.M. Engber, M. Bonastre, T.N. Chase, and E. Tolosa Effect of long-term haloperidol treatment on striatal neuropeptides: relation to stereotyped behavior Brain Res. 731 1996 57 62
26. M.dos S. Medeiros, and A.J. Turner Metabolism and functions of neuropeptide Y Neurochem. Res. 21 1996 1125 1132
27. E. Meller, F. Bordi, and K. Bohmaker Behavioral recovery after irreversible inactivation of D-1 and D-2 dopamine receptors Life Sci. 44 1989 1019 1026
28. G.E. Meredith, I.E. De Souza, T.M. Hyde, G. Tipper, M.L. Wong, and M.F. Egan Persistent alterations in dendrites, spines, and dynorphinergic synapses in the nucleus accumbens shell of rats with neuroleptic-induced dyskinesias J. Neurosci. 20 2000 7798 7806
29. L.P. Midgley, N.A. Singh, L.G. Bush, J.W. Gibb, and G.R. Hanson Characterization of phencyclidine-induced effects on neuropeptide Y systems in the rat caudate-putamen Brain Res. 593 1992 89 96
30. L.P. Midgley, J.D. Wagstaff, N.A. Singh, L.G. Bush, J.W. Gibb, and G.R. Hanson Dynamic dopaminergic regulation of neuropeptide Y systems in discrete striatal and accumbens regions Eur. J. Pharmacol. 251 1994 191 199
31. M. Miyake, K. Iguchi, H. Okamura, K. Fukui, T. Nakajima, K. Chihara, Y. Ibata, and N. Yanaihara Effect of haloperidol on immunoreactive neuropeptide Y in rat cerebral cortex and basal ganglia Brain Res. Bull. 25 1990 263 269
32. E. Moore, Z. Merali, and R.J. Beninger Neuropeptide Y: intrastriatal injections produce contralateral circling that is blocked by a dopamine antagonist in rats Pharmacol. Biochem. Behav. 48 1994 681 688
33. E. Obuchowicz Differential effect of quinpirole in neuroleptic-pretreated rats - role of α1-adrenoceptor Eur. J. Pharmacol. 384 1999 101 109
34. E. Obuchowicz, L. Antkiewicz-Michaluk, I. Romańska, and Z.S. Herman Increased striatal neuropeptide Y immunoreactivity and its modulation by deprenyl, clonidine and L-dopa in MPTP-treated mice J. Neural. Transm. 110 2003 1375 1391
35. E. Obuchowicz, R. Krysiak, and Z.S. Herman Does neuropeptide Y(NPY) mediate the effects of psychotropic drugs? Neurosci. Biobehav. Rev. 28 2004 595 610
36. E. Obuchowicz, and J. Turchan Influence of typical and atypical antipsychotics on neuropeptide Y-like immunoreactivity and NPY mRNA expression in rat striatum Neuropeptides 32 1998 473 480
37. E. Obuchowicz, and J. Turchan Effects of acute or long-term treatment with chlorpromazine, haloperidol or sulpiride on neuropeptide Y-like immunoreactivity in the nucleus accumbens of rat Eur. Neuropsychopharmacol. 9 1999 51 59
38. K. Ossowska Neuronal basis of neuroleptics-induced extrapyramidal side effects Pol. J. Pharmacol. 54 2002 299 313
39. R. Öhman, M. Larrson, I.M. Nilsson, J. Engel, and A. Carlsson Neurometabolic and behavioural effects of haloperidol in relation to drug levels in serum and brain Naunyn-Schmiedeberg's Arch. Pharmacol. 299 1977 105 114
40. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates second ed. 1986 Academic Press Sydney
41. C.M.A. Pennartz, H.J. Groenewegen, and F.H. Lopes da Silva The nucleus accumbens as a complex of functionally distinct neuronally ensembles: an integration of behavioural, electrophysiological and anatomical data Prog. Neurobiol. 42 1994 719 761
42. E.S. Prosser, R. Pruthi, and J.G. Csernansky Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride Psychopharmacology 99 1989 109 116
43. K. Sakai, K. Maeda, K. Chihara, and H. Kaneda Increases in cortical neuropeptide Y and somatostatin concentration following haloperidol-depot treatment in rats Neuropeptides 29 1995 157 161
44. P. Salin, L. Kerkerian, and A. Nieoullon Expression of neuropeptide Y immunoreactivity in the rat nucleus accumbens is under the influence of the dopaminergic mesencephalic pathway Exp. Brain Res. 81 1990 363 371
45. P. Salin, A. Nieoullon, and L. Kerkerian-Le Goff Reversal of the adaptive response of neuropeptide Y neurons in the rat striatum to nigrostriatal dopamine deafferentation by the N-methyl-d-aspartate antagonist dizocilpine maleate Neuroscience 61 1994 93 105
46. 1 receptors Life Sci. 44 1989 229 236
47. 2 receptor agonists and antagonists Neuropharmacology 30 1991 1269 1274
48. M. Smialowska, M. Bajkowska, B. Przewlocka, M. Maj, J. Turchan, and R. Przewlocki Effect of 6-hydroxydopamine on neuropeptide Y and corticotropin-releasing factor expression in rat amygdala Neuroscience 94 1999 1125 1132
49. Y. Tatsuoka, P.N. Riskind, M.F. Beal, and J.B. Martin The effect of amphetamine on the in vivo release of dopamine, somatostatin and neuropeptide Y from caudate nucleus Brain Res. 411 1987 200 203
50. W. Timmerman, J.B. De Vries, and B.H.C. Westerink Effects of D-2 agonists on the release of dopamine: localization of the mechanism of action Naunyn-Schmiedeberg's Arch. Pharmacol. 342 1990 650 654
51. C. Van Hartesveldt, G.A. Cottrell, T. Potter, and M.E. Meyer Effects of intracerebral quinpirole on locomotion in rats Eur. J. Pharmacol. 214 1992 27 32
52. J. Vuillet, L. Kerkerian, P. Kachidian, O. Bosler, and A. Nieoullon Ultrastructural correlates of functional relationships between nigral dopaminergic or cortical afferent fibers and neuropeptide Y containing neurons in the rat striatum Neurosci. Lett. 100 1989 99 104
53. S.M. Waters, C.S. Konkoy, and T. Davis Haloperidol and apomorphine differentially affect neuropeptidase activity J. Pharmacol. Exp. Ther. 277 1996 113 120
54. FJ. White, LM. Bednarz, SR. Wachtel, S. Hjorth, and RJ. Brooderson Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors? Pharmacol. Biochem. Behav. 30 1988 189 193
55. W.S. Young III, T.I. Bonner, and M.R. Brann Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain Proc. Natl. Acad. Sci. USA 83 1986 9827 9831